A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
Status:
Recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Cadonilimab Injection in combination with Regorafenib
in the treatment of intermediate to advanced hepatocellular carcinoma that has failed at
least one prior systemic therapy .
Phase:
Phase 1
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital